4.4 Review

Regulation of muscle potassium: exercise performance, fatigue and health implications

期刊

EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
卷 121, 期 3, 页码 721-748

出版社

SPRINGER
DOI: 10.1007/s00421-020-04546-8

关键词

Skeletal muscle; Cardiac muscle; Hyperkalaemia; Hypokalaemia; Na+; K+-ATPase

向作者/读者索取更多资源

This review integrates the current understanding of the role of skeletal muscle in whole-body potassium regulation, focusing on the regulation of skeletal muscle K+. It discusses how K+ transport proteins in skeletal muscle contribute to K+ disturbances during exercise and the implications on muscle and cardiac muscle contractile performance. The review also examines the implications of moderate plasma and interstitial K+ elevations during exercise and the dangerous health implications of chronic or acute changes in arterial plasma K+ levels.
This review integrates from the single muscle fibre to exercising human the current understanding of the role of skeletal muscle for whole-body potassium (K+) regulation, and specifically the regulation of skeletal muscle [K+]. We describe the K+ transport proteins in skeletal muscle and how they contribute to, or modulate, K+ disturbances during exercise. Muscle and plasma K+ balance are markedly altered during and after high-intensity dynamic exercise (including sports), static contractions and ischaemia, which have implications for skeletal and cardiac muscle contractile performance. Moderate elevations of plasma and interstitial [K+] during exercise have beneficial effects on multiple physiological systems. Severe reductions of the trans-sarcolemmal K+ gradient likely contributes to muscle and whole-body fatigue, i.e. impaired exercise performance. Chronic or acute changes of arterial plasma [K+] (hyperkalaemia or hypokalaemia) have dangerous health implications for cardiac function. The current mechanisms to explain how raised extracellular [K+] impairs cardiac and skeletal muscle function are discussed, along with the latest cell physiology research explaining how calcium, beta-adrenergic agonists, insulin or glucose act as clinical treatments for hyperkalaemia to protect the heart and skeletal muscle in vivo. Finally, whether these agents can also modulate K+-induced muscle fatigue are evaluated.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据